Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PBMs Would Compete For Medicare Enrollees Under Sen. Roth's Rx Drug Plan

Executive Summary

Medicare would contract with multiple pharmaceutical benefit managers in each service area under Sen. Roth's (R-Del.) Medicare reform plan.

You may also be interested in...



Medicare Rx Debate Moves To Center Of Presidential Campaigns

The outcome of House/Senate negotiations over drug re-importation and taxpayer funded research will be the most pressing pharmaceutical-related issues in Washington, D.C., as the Medicare drug benefit debate takes center stage in the Presidential campaign.

Medicare Rx Debate Moves To Center Of Presidential Campaigns

The outcome of House/Senate negotiations over drug re-importation and taxpayer funded research will be the most pressing pharmaceutical-related issues in Washington, D.C., as the Medicare drug benefit debate takes center stage in the Presidential campaign.

Medicare Rx Mark-Up By Senate Finance Delayed Until After Recess

The Senate Finance Committee will not mark up Medicare reform legislation that would establish a prescription drug benefit until after the August congressional recess.

Related Content

UsernamePublicRestriction

Register

PS036427

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel